Quarterly Results of Operations (Unaudited)

3 Months Ended

12 Months Ended

Mar. 30, 2012

Mar. 30, 2012

Quarterly Financial Information Disclosure [Abstract]

QUARTERLY RESULTS OF OPERATIONS (UNAUDITED)

The Company reports its year-end and quarter-end financial position, results of operations, and cash flows as of the Friday closest to calendar month end, determined using the number of business days. As disclosed in the table above, the selling days may fluctuate between each quarter and/or differ from the previous fiscal year.

Fiscal Year 2012

During the three months ended March 30, 2012, the Company issued $250.0 million aggregate principal amount of 6.375% senior notes due 2022 in a private offering. The 2012 Notes were issued under an Indenture, dated February 24, 2012 among the Company, the Guarantors and U.S. Bank National Association, as trustee. Interest on the notes is payable semi-annually in arrears on March 1 and September 1, beginning September 1, 2012. Refer to 12, Debt, for further discussion. During the three months ended March 30, 2012, the Company recognized a decrease in accrued incentive and stock-based compensation expense of $7,358 related to payout estimates based on performance, which is reflected in Net income attributable to PSS World Medical, Inc. in the table above.

Fiscal Year 2011

During the three months ended April 1, 2011, the Company purchased 100% of the outstanding stock of Dispensing Solutions, Inc. (“DSI”). DSI, a formerly privately held company based in California, markets a proprietary system to primary care physicians for dispensing medications to patients on-site within their practices. The acquisition price for DSI was approximately $36,000, with additional consideration of up to $6,000 if the company achieved defined earnings targets over a one year period. Net sales related to the DSI acquisition during the three months ended April, 1, 2011, was approximately $6,595. Refer to Footnote 4, Purchase Business Combinations, for further discussion.

The following tables present summarized unaudited quarterly results of operations for fiscal years 2012 and 2011. The Company believes all necessary adjustments have been included in the amounts stated below to present fairly the following selected information when read in conjunction with the consolidated financial statements of the Company. Future quarterly operating results may fluctuate depending on a number of factors, including the number of selling days in a quarter, the timing of business combinations, and changes in customer's buying patterns of supplies, equipment, and pharmaceutical products. Results of operations for any particular quarter are not necessarily indicative of results of operations for a full year or any other quarter.

		Fiscal Year 2012
		Q1		Q2		Q3		Q4		Total
Net sales		$	513,682	$	521,756	$	527,695	$	538,869	$	2,102,002
Gross profit			160,757		167,103		170,495		175,848		674,203
Net income attributable to PSS World Medical, Inc.			14,189		20,031		20,132		19,967		74,319
Earnings per common share attributable to PSS World Medical, Inc.:
	Basic	$	0.26	$	0.38	$	0.39	$	0.40	$	1.43
	Diluted	$	0.25	$	0.37	$	0.38	$	0.38	$	1.38
Selling days			64		63		62		64		253
		Fiscal Year 2011
		Q1		Q2		Q3		Q4		Total
Net sales		$	478,856	$	496,188	$	510,087	$	549,658	$	2,034,789
Gross profit			147,846		157,125		157,895		172,905		635,771
Net income attributable to PSS World Medical, Inc.			13,753		19,557		19,549		21,626		74,485
Earnings per common share attributable to PSS World Medical, Inc.:
	Basic	$	0.25	$	0.36	$	0.36	$	0.40	$	1.35
	Diluted	$	0.24	$	0.35	$	0.35	$	0.38	$	1.32
Selling days			64		63		61		65		253